- Your body already makes GLP-1 every time you eat. Protein, soluble fibre, fermented foods and post-meal walking all raise it measurably — and that is where we start.
- Standard doses cost you muscle. Body composition analyses have found lean tissue accounting for roughly a quarter to forty percent of total weight lost without a protein and training protocol.
- Losing muscle worsens the metabolism you were trying to fix. Muscle is your largest glucose sink, so losing it lowers metabolic rate and pushes insulin back up.
- If medication is genuinely needed, microdose it. A lower dose alongside real food changes keeps appetite workable, reduces side effects and protects lean tissue.
- Weight regain after stopping is well documented, which is why what you build while appetite is suppressed matters more than the number on the scale.
How to raise your own GLP-1 first
This is the part of the conversation that almost never happens before someone is handed a prescription, and in my experience it is where a great many people could have started.
GLP-1 is not a drug. It is a hormone your gut releases every time you eat, and how much you release depends heavily on what you eat and how you live. What we do in the clinic is work on that first, measure the result, and only then talk about medication.
Here is what actually raises it.
- Protein at the front of every meal. Protein is the strongest single stimulus for GLP-1 release. Eating it first, before the starch, produces a measurably different hormonal response from the same meal eaten in the opposite order.
- Soluble fibre, and plenty of it. When fibre reaches the lower small intestine and colon it triggers GLP-1 release directly. Oats, barley, legumes, chia, ground flax, psyllium. Most people eat a third of what they need.
- Short-chain fatty acids from fermentation. Your gut bacteria produce butyrate from fibre, and butyrate stimulates the same L-cells that release GLP-1. This is one of the more direct links between gut health and appetite regulation.
- Bitter foods and herbs. Bitter receptors in the gut trigger GLP-1 release. Rocket, radicchio, dandelion greens, gentian, berberine. This is old traditional practice with a modern mechanism underneath it.
- Walking after meals. Ten minutes. It improves glucose clearance and supports the incretin response, and it is free.
- Healthy fats, particularly olive oil and omega-3s. Fat slows gastric emptying and stimulates GLP-1 in its own right.
- Enough sleep. Short sleep raises ghrelin and lowers satiety signalling, which works directly against everything above.
What we have seen with patients is that a meaningful number who arrive convinced they need an injection do not, once these are genuinely in place and the metabolic drivers underneath — insulin, thyroid conversion, cortisol, iron — have been corrected. That is not a criticism of anyone who ends up needing medication. It is simply that this deserves a proper attempt first.
How GLP-1 medications actually work
GLP-1 is a hormone your gut already produces after eating. These medications are long-acting versions of a signal you already run on.
Glucagon-like peptide-1 is released by intestinal cells in response to food. It does several things at once: it slows gastric emptying so food stays in the stomach longer, it signals satiety in the hypothalamus, and it enhances glucose-dependent insulin release from the pancreas.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual agonist, acting on both GLP-1 and GIP receptors, which is part of why it tends to produce greater weight loss in head-to-head comparison.
The subjective experience most patients describe is what is often called quieting of “food noise” — the constant background negotiation about eating simply stops. For someone who has spent decades fighting that, it can be genuinely transformative, and I do not want to understate how meaningful that is.
The problem nobody mentions at the point of sale
This is the part I care most about, and it is the reason we will not simply write a prescription and hand you an injection schedule.
All rapid weight loss costs some lean tissue. That is not unique to these medications. What is different here is the rate and the mechanism: appetite is suppressed profoundly, and when someone eats substantially less without deliberately protecting protein intake, the body takes what it needs from muscle.
Analyses of body composition in GLP-1 trials have found that lean mass can account for roughly a quarter to forty percent of total weight lost when no resistance training or protein strategy is in place.
Here is why that matters beyond aesthetics. Muscle is the largest glucose disposal site in your body. Lose it and your resting metabolic rate falls, your glucose disposal capacity falls, and your insulin resistance gets worse — which is the exact metabolic problem the medication was prescribed to address. You can arrive lighter and metabolically worse off.
And it compounds. If the weight returns after stopping — and the data says it very often does — it returns predominantly as fat. So the ratio of muscle to fat can end up worse than before you started.
If you do need medication, microdose it
When someone has genuinely done the work above and still needs help, my position is that the dose most people are put on is higher than it needs to be.
The standard titration schedule was designed around trial endpoints, not around preserving lean tissue. What I have seen clinically is that a meaningful number of patients get most of the appetite benefit at a fraction of the standard dose — with far fewer side effects and considerably less muscle loss.
Microdosing means starting lower and escalating only if genuinely needed, rather than following a fixed schedule upward regardless of response. The advantages are practical: appetite is suppressed enough to change habits but not so profoundly that hitting a protein target becomes impossible. Nausea and gastrointestinal side effects drop substantially. And because the deficit is more moderate, less of what comes off is lean tissue.
It also makes the exit easier. Someone who reached their goal on a small dose has a much shorter distance to taper than someone who spent a year at the maximum.
Natural GLP-1 support and the metabolic workup come first, always. If medication is still warranted after that, we start at the lowest dose that produces a response, hold there rather than escalating on schedule, and track lean mass alongside fat mass so we can see immediately if the wrong tissue is leaving.
How we run it differently
Same medication, entirely different protocol around it. Four non-negotiables.
1. We work the metabolism up first. Fasting insulin, HOMA-IR, full thyroid panel, cortisol rhythm, sex hormones and hs-CRP. Sometimes that workup shows something correctable that changes the plan — and occasionally it shows someone does not need the medication at all.
2. A protein target, set and tracked. Typically 1.2 to 1.6 grams per kilogram of goal body weight, which is materially higher than most people eat. This is difficult on a medication that suppresses appetite, which is exactly why it needs to be planned rather than hoped for.
3. Resistance training, non-negotiable. Two to three sessions weekly, minimum. Protein supplies the material; training supplies the signal to keep it. Neither works properly without the other.
4. Body composition, not scale weight. We track lean mass and fat mass separately. The scale cannot tell you whether a good month or a bad one just happened, and on these medications that distinction is the whole ballgame.
What happens when you stop
The question every patient should ask before starting, and the one most rarely answered honestly.
Discontinuation studies have consistently shown substantial weight regain after stopping — in the region of two-thirds of lost weight within a year in some analyses. This is not a failure of willpower. It is what happens when you remove an appetite signal the body had adapted around.
Which leaves three honest positions. Some people will stay on a maintenance dose long term, and for some that is entirely reasonable. Some will taper slowly with the metabolic drivers corrected underneath, which is where the workup earns its place. And some will regain, which is a real outcome that should be discussed before starting rather than discovered afterwards.
What clearly improves the odds: muscle preserved through the losing phase, insulin genuinely corrected rather than only masked, and eating patterns established while appetite is suppressed so they persist when it returns.
The ten rules we run weight loss by
In order of how much each one determines whether you end up genuinely better off, rather than simply lighter.
Raise Your Own GLP-1 First
Protein at the front of every meal, soluble fibre, fermented foods, bitter greens and a ten-minute walk afterwards. These raise the same hormone the injection mimics, and in my experience a meaningful number of patients do not need medication once these are genuinely in place.
What the evidence showsDietary protein is the strongest stimulus for endogenous GLP-1 secretion from intestinal L-cells. Meal sequencing studies show protein consumed before carbohydrate produces a measurably different incretin and glucose response from the identical meal reversed.Work the Metabolism Up Before Any Prescription
Fasting insulin, full thyroid, cortisol rhythm, sex hormones and inflammatory markers. What we find with patients is that this frequently changes the plan entirely, and sometimes shows the medication was never the answer.
What the evidence showsFasting insulin, thyroid function, cortisol rhythm and inflammatory markers each independently affect weight regulation, and a workup identifies correctable drivers before pharmacological appetite suppression is introduced.Set a Protein Target and Track It
1.2 to 1.6 g per kg of goal weight. On a medication that suppresses appetite this requires deliberate planning — usually protein first at every meal and often a shake to close the gap.
What the evidence showsResistance training is the primary signal for muscle protein synthesis during a caloric deficit. Without it, a substantial proportion of weight lost is lean tissue regardless of protein intake.Resistance Train Twice Weekly, Minimum
Protein is the material; training is the signal. Without the signal the body will not prioritise keeping muscle during a large deficit, regardless of intake.
What the evidence showsBody composition analysis distinguishes fat mass from lean mass, which scale weight cannot. Lean mass loss during rapid weight reduction has been reported at 25 to 40 percent of total weight lost without a protein and training protocol.Measure Body Composition, Not Weight
Lean mass and fat mass separately, at baseline and repeatedly. This is the only way to know whether the last two months were a success or a slow-motion problem.
What the evidence showsSlower dose escalation reduces gastrointestinal adverse events and improves adherence in GLP-1 trials, and a more moderate deficit reduces the proportion of weight lost as lean tissue.Titrate Slowly
Faster escalation produces more nausea, worse adherence and greater lean loss. The slower ramp costs a few weeks and protects both the experience and the outcome.
What the evidence showsReduced caloric intake proportionally reduces micronutrient intake. Iron, B12, vitamin D and magnesium deficiency during treatment produce fatigue that is frequently attributed to the deficit rather than to deficiency.Correct Nutrients Deliberately
Eating far less means absorbing far less. Iron, B12, vitamin D and magnesium all commonly fall on these medications, and the resulting fatigue gets blamed on the deficit rather than the deficiency.
What the evidence showsDelayed gastric emptying is the primary mechanism and the primary side effect. Smaller meal volume, adequate hydration and reduced fat content per meal measurably improve tolerance.Support Digestion
Slowed gastric emptying is the mechanism, and it is also the side effect. Smaller meals, adequate hydration, digestive support and avoiding large fatty meals make the difference between tolerable and miserable.
What the evidence showsDiscontinuation studies including the STEP 1 trial extension documented regain of approximately two-thirds of lost weight within one year of stopping, with cardiometabolic improvements reverting in parallel.Plan the Exit at the Start
Discontinuation data shows substantial regain. Deciding in advance whether this is a bridge or a long-term therapy, and building the eating and training patterns while appetite is suppressed, is what determines what happens afterwards.
What the evidence showsAdding aggressive caloric restriction to profound pharmacological appetite suppression increases risk of lean mass loss, gallstone formation and micronutrient deficiency without improving fat loss proportionally.Retest and Reassess
Repeat panel at twelve weeks. Insulin, thyroid, lipids and nutrient status. The goal is a metabolism that is genuinely better, not merely a smaller version of the same problem.
What the evidence showsRepeat panel assessment at twelve weeks distinguishes genuine metabolic improvement from weight reduction alone. Fasting insulin, HbA1c and hs-CRP should improve alongside body composition.What patients commonly experience under our care
When patients receive the proper guidance, here is what they commonly experience under our care.
- Week 1 — the food noise stops. Almost universally the first thing described, and for many people the most striking. The constant background negotiation about eating simply goes quiet.
- Weeks 2–6 — weight moves and side effects settle. Nausea is common early and usually eases with slower titration and smaller meals. This is where a protein target and training become essential rather than optional.
- Weeks 8–12 — the panel and the composition scan. Fasting insulin falling, HbA1c improving, hs-CRP down — and lean mass held. This is the checkpoint that tells us whether this is going well or quietly going wrong.
- Months 3–6 — the part that lasts. Strength maintained or improved, fat mass down, waist down. And the eating and training patterns established while appetite was suppressed, which is what determines what happens when the medication stops.
Before you reach for an injection, let us find out what is actually driving the weight. Schedule a consultation and my team will work up the metabolism, raise your own GLP-1 naturally, and only consider medication — microdosed and alongside a protein plan — if you genuinely still need it. You deserve to end up healthier, not just lighter.
A full metabolic workup, a protein target, a training plan and body composition tracking — alongside the prescription, not instead of it.
Common questions
Do GLP-1 medications cause muscle loss?
They can, and it is the main thing to plan around. Body composition analyses have found lean mass accounting for roughly a quarter to forty percent of total weight lost when no protein strategy or resistance training is in place. That matters because muscle is your largest glucose sink, so losing it worsens the metabolic picture the medication was prescribed to improve.
How do I avoid losing muscle on semaglutide?
Three things, together. A protein target of roughly 1.2 to 1.6 g per kg of goal body weight, tracked rather than estimated. Resistance training at least twice weekly. And slower dose titration, since faster escalation produces greater lean loss. Body composition monitoring tells you whether it is working.
What happens if I stop taking a GLP-1?
Discontinuation studies consistently show substantial weight regain — around two-thirds of lost weight within a year in some analyses. This reflects removing an appetite signal the body adapted around rather than any failure of willpower. It is why we plan the exit at the start and why correcting the underlying metabolic drivers matters.
Is tirzepatide better than semaglutide?
Tirzepatide acts on both GLP-1 and GIP receptors and has produced greater average weight loss in head-to-head comparison. Better for an individual depends on tolerance, cost, coverage and what the metabolic workup shows. Neither is better without the protein and training protocol around it.
Do I need bloodwork before starting a GLP-1?
We would say yes. Fasting insulin, full thyroid, cortisol rhythm, sex hormones and inflammatory markers tell us what is actually driving the weight, whether something correctable is in the way, and give us a baseline to measure against. Occasionally that workup shows the medication is not what the person needs.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989–1002.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205–216.
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553–1564. PMC9542252
- Conte C, et al. Is weight loss-induced muscle mass loss clinically relevant? JAMA. 2024;332(1):9–10.
This article is educational and reflects the published literature as of August 2026. It is not a diagnosis or a treatment recommendation for any individual, and any decision about your care belongs in a conversation with a licensed practitioner who has seen your history and your labs.
